JSM Activity #470

This is the preliminary program for the 2003 Joint Statistical Meetings in San Francisco, California. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 2-5, 2003); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions.

To View the Program:
You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time.

The views expressed here are those of the individual authors
and not necessarily those of the ASA or its board, officers, or staff.

Back to main JSM 2003 Program page
Legend: = Applied Session, = Theme Session, = Presenter
Hotels: H = Hilton San Francisco, R = Reniassance Parc Hotel 55, N = Nikko San Francisco
Add To My Program
470 Applied Session Thu, 8/7/03, 10:30 AM - 12:20 PM R-Parc Ballroom I
Issues of Study Design - Contributed - Papers
Biometrics Section
Chair(s): Rebecca A. Betensky, Harvard School of Public Health
     10:35 AM   Estimates, Power and Sample Size Calculations for Two-Sample Ordinal Outcomes under Before-After Study Designs — Pamela A. Ohman Strickland, UMDNJ; Shou-En Lu, University of Medicine and Dentistry of New Jersey
     10:50 AM   Sample Size and Power in Survival Changepoint model — Ramin B. Arani, Johnson & Johnson Pharmaceutical Research and Development, LLC; Youn C. Park, Johnson & Johnson Pharmaceutical Research and Development, LLC; Seng-Jaw Soong, University of Alabama
     11:05 AM   Two-Stage Designs for Stratified Phase 2 Clinical Trials — Myron N. Chang, University of Florida; Wendy B. London, University of Florida
     11:20 AM   Estimation of Sample Size for Reference Interval Studies — James F. Troendle, National Institutes of Health; Kai Fun Yu, National Institutes of Health
     11:35 AM   Power and Sample Size Calculation for Clinical Trials with Recurrent Event Data — Chin-Yu Lin, National Health Research Institutes; Jen-Pei Liu, National Cheng-Kung University; Sue-Jane Wang, Food and Drug Administration
     11:50 AM   Alpha Allocation and Interpretation of Composite Endpoints in Clinical Trials — Lemuel A. Moye, University of Texas
     12:05 PM   Floor Discussion
 

JSM 2003 For information, contact meetings@amstat.org or phone (703) 684-1221. If you have questions about the Continuing Education program, please contact the Education Department.
Revised March 2003